HLA-DRB1 and myeloid sarcoma: Although the exact mechanisms by which HLA products encoded by different DRB1 alleles contribute to MS susceptibility are still unknown, the parameters of autoantigen binding to HLA proteins may be the key component determining predisposing or protective effects of HLA allelic variants on MS development.